We are live on ! Find out more
OLA

Oliver Luxxe Assets Portfolio holdings

AUM $680M
1-Year Est. Return 47.51%
This Fund
S&P 500
This Quarter Est. Return
-21.26%
1 Year Est. Return
+47.51%
3 Year Est. Return
+141.35%
5 Year Est. Return
+220.75%
10 Year Est. Return
+625.72%
AUM
$160M
AUM Growth
-$31.9M
Cap. Flow
+$2.28M
Cap. Flow %
1.43%
Top 10 Hldgs %
22.91%
Holding
141
New
16
Increased
62
Reduced
26
Closed
27

Sector Composition

Rank Sector Weight
1 Healthcare 17.21%
2 Technology 14.99%
3 Financials 13.71%
4 Industrials 11.09%
5 Communication Services 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
1
Merck
MRK
$324B
$4.6M 2.89%
59,100
+4,254
+8% +$334K
TGT icon
2
Target
TGT
$62.1B
$4.47M 2.8%
42,690
+3,097
+8% +$344K
MSFT icon
3
Microsoft
MSFT
$2.84T
$4.25M 2.67%
25,749
+17,621
+217% +$2.9M
INTC icon
4
Intel
INTC
$466B
$3.52M 2.2%
59,599
-4,230
-7% -$250K
AAPL icon
5
Apple
AAPL
$4.89T
$3.39M 2.13%
51,020
-22,976
-31% -$1.69M
VGT icon
6
Vanguard Information Technology ETF
VGT
$139B
$3.35M 2.1%
119,488
-3,376
-3% -$102K
HON icon
7
Honeywell
HON
$77.1B
$3.28M 2.06%
24,980
+850
+4% +$131K
CMCSA icon
8
Comcast
CMCSA
$79.1B
$3.26M 2.04%
86,442
+5,893
+7% +$249K
PM icon
9
Philip Morris
PM
$301B
$3.25M 2.04%
43,580
-4,145
-9% -$341K
PFE icon
10
Pfizer
PFE
$140B
$3.19M 2%
97,065
-19,436
-17% -$662K
V icon
11
Visa
V
$677B
$3.13M 1.96%
17,905
+5,118
+40% +$964K
TMO icon
12
Thermo Fisher Scientific
TMO
$211B
$2.96M 1.86%
9,651
+380
+4% +$120K
BRK.A icon
13
Berkshire Hathaway Class A
BRK.A
$1.07T
$2.87M 1.8%
10
META icon
14
Meta Platforms (Facebook)
META
$1.51T
$2.85M 1.78%
16,337
+15,356
+1,565% +$3.01M
BMY icon
15
Bristol-Myers Squibb
BMY
$127B
$2.82M 1.77%
+48,370
New +$2.96M
ZBH icon
16
Zimmer Biomet
ZBH
$17.7B
$2.78M 1.74%
25,749
+6,390
+33% +$838K
JPM icon
17
JPMorgan Chase
JPM
$939B
$2.75M 1.73%
29,215
+1,218
+4% +$148K
WTW icon
18
Willis Towers Watson
WTW
$27.9B
$2.71M 1.7%
14,276
+89
+0.6% +$17.5K
MS icon
19
Morgan Stanley
MS
$337B
$2.7M 1.69%
+68,669
New +$3.23M
VGK icon
20
Vanguard FTSE Europe ETF
VGK
$30B
$2.66M 1.66%
60,032
+2,858
+5% +$151K
CVS icon
21
CVS Health
CVS
$137B
$2.63M 1.65%
44,340
+15,615
+54% +$1.04M
CVX icon
22
Chevron
CVX
$388B
$2.52M 1.58%
29,317
+149
+0.5% +$14.7K
LOW icon
23
Lowe's Companies
LOW
$116B
$2.43M 1.53%
25,788
+19,090
+285% +$2.09M
DIS icon
24
Walt Disney
DIS
$165B
$2.37M 1.48%
23,408
+9,779
+72% +$1.24M
NKE icon
25
Nike
NKE
$61.9B
$2.35M 1.47%
27,547
+24,062
+690% +$2.24M

Similar funds

Oliver Luxxe Assets's Q1 2020 Portfolio in Review

As of Q1 2020, Oliver Luxxe Assets held 141 positions worth $160M, down 17% from $191M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Oliver Luxxe Assets's Q1 2020 filing shows 16 new, 62 increased, 26 reduced and 27 closed positions. Its largest new stake was Morgan Stanley: 68,669 shares worth $2.7M. The largest sale was Johnson & Johnson, an estimated $3.98M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 14% a quarter earlier, followed by Technology and Financials.

  • Oliver Luxxe Assets's largest Q1 2020 buy was Morgan Stanley: 68,669 shares worth $2.7M.
  • Oliver Luxxe Assets added most to Meta Platforms (Facebook) in Q1 2020, an estimated $3.01M increase.
  • Oliver Luxxe Assets's biggest Q1 2020 reduction was Johnson & Johnson, cutting an estimated $3.98M.
  • Oliver Luxxe Assets fully exited Citizens Financial Group in Q1 2020, selling an estimated $3.19M.
  • Oliver Luxxe Assets's ten largest holdings make up 23% of its $160M portfolio in Q1 2020.
  • Oliver Luxxe Assets opened 16 new positions and closed 27 in Q1 2020.
  • Oliver Luxxe Assets's portfolio value fell 17% quarter-over-quarter to $160M.

Based on Oliver Luxxe Assets's 13F filing for Q1 2020, filed 21 Apr 2020.